The Royal Pharmaceutical Society (RPS) said despite the "incredibly exciting age" we live in, the market is "not set up to incentivise the production of new types of medicines".
RPS chief scientist Professor Jayne Lawrence said: "The current crisis in antimicrobial resistance is in part due to the lack of new classes of antibiotics coming on the market.
"Antibiotics can cure infections in weeks, so the volume of sales of drugs is low. This doesn't allow the tens or even hundreds of millions required for research and development to be recouped.
"Unless we find a way to develop treatments that cure illnesses in months, rather than treat symptoms for years, we will not see the breakthroughs that both scientists and patients want."
More top news
Police have revealed a pair of sandals they have had made similar to the pair Ben is thought to have been wearing when he disappeared
The hospital was last attacked just three days ago, something that UN Secretary General Ban Ki Moon denounced as a war crime.
Former UKIP leader Nigel Farage has flown to the US to help coach presidential candidate Donald Trump ahead of his next debate.